| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 01/25/2012 | CN102329393A Monoclonal antibody resisting Abeta (beta-amyloid) 42 peptide and application thereof |
| 01/25/2012 | CN102329325A Pyrrolopyrimidone dipeptidyl peptidase-IV (DPP-IV) inhibitors |
| 01/25/2012 | CN102329278A Zonisamide crystal, preparation method thereof and medicinal composition containing zonisamide crystal |
| 01/25/2012 | CN102329267A 6-substituted 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists |
| 01/25/2012 | CN102327613A Application of ErbB receptor stimulant to preparation of medicament for treating epilepsy |
| 01/25/2012 | CN102327602A Pharmaceutical composition comprising botulinum, a non ionicsurfactant, sodium chloride and sucrose |
| 01/25/2012 | CN102327573A Traditional Chinese medicine formula for treating viscera |
| 01/25/2012 | CN102327568A Medicine for treating senile dementia |
| 01/25/2012 | CN102327558A Traditional Chinese medicine for treating depression after apoplexia |
| 01/25/2012 | CN102327557A Anxiety-removing calming traditional Chinese medicine decoction for treating anxiety neurosis |
| 01/25/2012 | CN102327555A Chinese herbal medicine for treating insomnia induced by liver fire derived from liver depression |
| 01/25/2012 | CN102327518A Traditional Chinese medicine for treating insomnia |
| 01/25/2012 | CN102327497A Method for preparing traditional Chinese medicine lotion for treating eclamptic bedsore |
| 01/25/2012 | CN102327495A Chinese herbal medicine for treating headache due to deficiency of blood |
| 01/25/2012 | CN102327494A Traditional Chinese medicine for treating migraine caused by liver-Yang hyperactivity |
| 01/25/2012 | CN102327468A Chinese herbal medicine for treating qi-blood deficiency induced insomnia |
| 01/25/2012 | CN102327464A Medicament for treating insomnia |
| 01/25/2012 | CN102327463A Traditional Chinese medicine composition for treating vertigo |
| 01/25/2012 | CN102327459A Chinese herbal medicine for treating liver/kidney yin deficiency neurasthenia |
| 01/25/2012 | CN102327458A Chinese herbal medicine for treating neurasthenia (deficiency of the heart-yin) |
| 01/25/2012 | CN102327456A Mind-tranquilizing and excitement-allaying medicinal liquor |
| 01/25/2012 | CN102327429A Chinese herbal medicine for treating spleen insufficiency and gastric retention insomnia |
| 01/25/2012 | CN102327405A Chinese medicine for treating diabetic peripheral neuropathy |
| 01/25/2012 | CN102327367A Chinese medicinal herb for treating heart-spleen deficiency and insomnia |
| 01/25/2012 | CN102327364A Traditional Chinese medicinal pill for treating viral meningitis |
| 01/25/2012 | CN102327352A Chinese herbal medicine for treating sciatica |
| 01/25/2012 | CN102327336A External sleeping patch |
| 01/25/2012 | CN102327325A Method for preparing white mulberry rootbark general flavone |
| 01/25/2012 | CN102327308A Smokeless moxibustion stick, preparation method thereof and quality control method |
| 01/25/2012 | CN102327276A Injecta for treating bacterial encephalitis of dog and preparation method thereof |
| 01/25/2012 | CN102327266A Pharmaceutical composition containing Iloperidone and preparation method thereof |
| 01/25/2012 | CN102327261A Method for purifying coriamyrtin substance |
| 01/25/2012 | CN102327257A Chlocibutamine slow release medicinal composition |
| 01/25/2012 | CN102327253A Minimizing adverse experience associated with oxybutynin therapy |
| 01/25/2012 | CN102327239A Salmon calcitonin nano liposome injection and preparation method thereof |
| 01/25/2012 | CN102327210A Vinpocetine suspension injection |
| 01/25/2012 | CN102327014A Bayberry pillow |
| 01/25/2012 | CN102078566B Medicine for treating schizophrenia |
| 01/25/2012 | CN102058842B Traditional Chinese medicine composition for treating hemiplegic stroke or premonitory apoplexy |
| 01/25/2012 | CN101953918B Chinese medicinal composition for treating cardiovascular and cerebrovascular diseases |
| 01/25/2012 | CN101919962B Medicine for curing insomnia and preparation method thereof |
| 01/25/2012 | CN101912434B Medicament for treating hypertension and insomnia and preparation method thereof |
| 01/25/2012 | CN101779884B Sedative traditional Chinese medicine health care pillow, pillowcase and medicine bag |
| 01/25/2012 | CN101732296B Agomelatine-containing medicinal composition |
| 01/25/2012 | CN101708230B Anti-drug medicine and preparation method thereof |
| 01/25/2012 | CN101703751B Emplastrum for treating white-plus disease and preparation method thereof |
| 01/25/2012 | CN101590114B Medicament for treating multiple sclerosis and preparation method thereof |
| 01/25/2012 | CN101584796B Application of traditional Chinese medicine composition in preparing medicament for treating melancholia |
| 01/25/2012 | CN101549046B Health preserving product of north Chinese Caterpillar Fungus and glossy ganoderma |
| 01/25/2012 | CN101461803B Use of grape inner ester |
| 01/25/2012 | CN101410393B Novel heteroaryl substituted benzothiazoles |
| 01/25/2012 | CN101301357B Use of schisandra chinensis extract in anti-depression medicament |
| 01/25/2012 | CN101242823B Composition comprising oleic acid and the use thereof |
| 01/25/2012 | CN101143135B Melatonin orally disintegrating tablet and preparation method thereof |
| 01/24/2012 | USRE43140 Immunoregulator |
| 01/24/2012 | US8101754 e.g., 2-tert-Butyl-4-{4-[3-(4-methyl-5-methyl-4H-[1,2,4]triazol-3-ylsulfanyl)-propyl]-piperazin-1-yl}-6-(1-methylcyclopropyl)-pyrimidine hydrochloride; central nervous system disorders; schizophrenia; antidepressant, anxiolytic agent, cognition activator; Parkinson's and Alzheimer's diseases |
| 01/24/2012 | US8101742 Method and medicament for inhibiting the expression of a given gene |
| 01/24/2012 | US8101661 Polar hydrophilic prodrugs and non-standard amino acid conjugates of amphetamine and other stimulants and processes for making and using the same |
| 01/24/2012 | US8101650 Method for treating a immunology-related disease |
| 01/24/2012 | US8101649 N-acylhydrazone derivatives useful as modulators of nicotinic acetylcholine receptors |
| 01/24/2012 | US8101638 6-substituted nicotinamide derivatives as opioid receptor antagonists |
| 01/24/2012 | US8101637 Alkynyl derivatives as modulators of metatropic glutamate receptors |
| 01/24/2012 | US8101599 Pharmaceutical composition containing anti-hypertensive agents |
| 01/24/2012 | US8101598 1,4-diaza-bicyclo[3.2.2]nonyl oxadiazolyl derivatives and their medical use |
| 01/24/2012 | US8101597 Quetiapine salts and their polymorphs |
| 01/24/2012 | US8101596 Loxapine analogs and methods of use thereof |
| 01/24/2012 | US8101584 A mammalian target gene and an exogenous oligoribonucleotide having a double stranded RNA; complementary region I is less than 49 nucleotides in length; cancer, viral diseases, neurodegenerative diseases |
| 01/24/2012 | US8101574 Oligopeptides and compositions containing the oligopeptides |
| 01/24/2012 | US8101573 α-conotoxin MII analogs |
| 01/24/2012 | US8101209 Absorption in upper part oof digestive system; oral administering |
| 01/24/2012 | US8101194 Immunogenic compositions for the prevention and treatment of meningococcal disease |
| 01/24/2012 | CA2674066C Therapeutic agent for diabetic neuropathy |
| 01/24/2012 | CA2666630C Agent for prophylaxis or treatment of alcohol dependence or drug dependence |
| 01/24/2012 | CA2656216C Compounds, compositions and methods for preventing neurodegeneration in acute and chronic injuries in the central nervous system |
| 01/24/2012 | CA2592102C Matrix type sustained-release preparation containing basic drug or salt thereof, and method for manufacturing the same |
| 01/24/2012 | CA2509088C Substituted 1-piperidin-3-yl-4-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists |
| 01/24/2012 | CA2499902C Composition with effects of decline prevention, improvement or enhancement of normal responses of cognitive abilities of a healthy person |
| 01/24/2012 | CA2499549C Isolation, purification and synthesis of procyanidin b2 and uses thereof |
| 01/24/2012 | CA2498559C Indole derivatives or benzimidazole derivatives for modulating i.kappa.b kinase |
| 01/24/2012 | CA2492848C Isolation and identification of t cells |
| 01/24/2012 | CA2471341C Crystalline form i of 2-methyl-4-(4-methyl-1-piperazinyl) 10h thieno [2,3-b][1,5]benzodiazepine |
| 01/24/2012 | CA2459577C An enantiomerically pure opioid diarylmethylpiperazine and methods of using same |
| 01/24/2012 | CA2455227C Use of biologically active hiv-1 tat, fragments or derivates thereof, to target and/or to activate antigen-presenting cells, and/or to deliver cargo molecules for preventive or therapeutic vaccination and/or to treat other diseases |
| 01/24/2012 | CA2440293C Catechins for the treatment of fibrillogenesis in alzheimer's disease, parkinson's disease, systemic aa amyloidosis, and other amyloid disorders |
| 01/24/2012 | CA2402092C 1,5-disubstituted-3,4-dihydro-1h-pyrimido[4,5-d]pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases |
| 01/24/2012 | CA2394327C Substituted piperazine and piperidine calcium channel blockers |
| 01/24/2012 | CA2370763C Peptide epitopes recognized by disease promoting cd4+ t lymphocytes |
| 01/24/2012 | CA2163748C Methods and compositions for inducing sleep |
| 01/19/2012 | WO2012009646A1 Methods of treating fragile x syndrome, down's syndrome, autism and related disorders |
| 01/19/2012 | WO2012009309A1 Compounds for the reduction of beta-amyloid production |
| 01/19/2012 | WO2012008984A1 (+)-morphinans as antagonists of toll-like receptor 9 and therapeutic uses thereof |
| 01/19/2012 | WO2012008782A2 Use of carbon nanotubes for preventing or treating brain disease |
| 01/19/2012 | WO2012008733A2 Stem cells derived from primary placenta tissue and cellular therapeutic agent containing same |
| 01/19/2012 | WO2012008549A1 Heterocyclic ring compound |
| 01/19/2012 | WO2012008528A1 Pyrazole compound |
| 01/19/2012 | WO2012008478A1 P2x4 receptor antagonist |
| 01/19/2012 | WO2012007836A1 Pyridine compounds as sodium channel blockers |
| 01/19/2012 | WO2012007777A1 Novel proteins, process for preparation thereof, and use thereof |
| 01/19/2012 | WO2012007658A2 Use of the pat nonapeptide in treating and preventing neurodegenerative diseases |
| 01/19/2012 | WO2012007627A1 Cyclic polyethers for treating and/or preventing tau- and beta-amyloid-linked neurodegenerative diseases |